|
"chiun sheng huang"的相關文件
顯示項目 356-365 / 438 (共44頁)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018 |
Effect of glucocorticoid use on survival in patients with stage I–III breast cancer
|
Lin C.-H.;Chuang P.-Y.;You S.-L.;Chiang C.-J.;Chiun-Sheng Huang;Wang M.-Y.;Chao M.;Lu Y.-S.;Cheng A.-L.;Tang C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; CHIUN-SHENG HUANG; Wang M.-Y.; Chao M.; Lu Y.-S.; Cheng A.-L.; Tang C.-H.; Lin C.-H. |
| 臺大學術典藏 |
2018 |
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
|
Kruper L.; Yuan Y.; Somlo G.; Mortimer J.; Chen S.; Petrossian K.; Kanaya N.; Lo C.; Hsu P.-Y.; Nguyen D.; Yang L.; Yang L.; Warden C.; Wu X.; Pillai R.; Bernal L.; CHIUN-SHENG HUANG; Petrossian K.;Kanaya N.;Lo C.;Hsu P.-Y.;Nguyen D.;Yang L.;Yang L.;Warden C.;Wu X.;Pillai R.;Bernal L.;Chiun-Sheng Huang;Kruper L.;Yuan Y.;Somlo G.;Mortimer J.;Chen S. |
| 臺大學術典藏 |
2018 |
Computer-Aided tumor diagnosis in 3-D breast elastography
|
Huang Y.-S.;Takada E.;Konno S.;Chiun-Sheng Huang;Kuo M.-H.;Chang R.-F.; Huang Y.-S.; Takada E.; Konno S.; CHIUN-SHENG HUANG; Kuo M.-H.; Chang R.-F. |
| 臺大學術典藏 |
2018 |
Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017: Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
|
on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; Xu B.; Whelan T.J.; Bonnefoi H.; Brucker S.Y.; Cardoso F.; Carey L.; Ciruelos E.; Cuzick J.; Denkert C.; Di Leo A.; Ejlertsen B.; Francis P.; Galimberti V.; Garber J.; Gulluoglu B.; Goodwin P.; Harbeck N.; Hayes D.F.; CHIUN-SHENG HUANG; Huober J.; Khaled H.; Jassem J.; Jiang Z.; Karlsson P.; Morrow M.; Orecchia R.; Osborne K.C.; Pagani O.; Partridge A.H.; Pritchard K.; Ro J.; Rutgers E.J.T.; Sedlmayer F.; Semiglazov V.; Shao Z.; Smith I.; Toi M.; Tutt A.; Viale G.; Watanabe T.; Bergh J.; Baselga J.; Thrlimann B.; Andr? F.; Senn H.-J.; Piccart-Gebhart M.; Regan M.M.; Colleoni M.; Loibl S.; Gnant M.; Winer E.P.; Burstein H.J.; Curigliano G.; Dubsky P.; Dubsky P.;Curigliano G.;Burstein H.J.;Winer E.P.;Gnant M.;Loibl S.;Colleoni M.;Regan M.M.;Piccart-Gebhart M.;Senn H.-J.;Thrlimann B.;Andr? F.;Baselga J.;Bergh J.;Bonnefoi H.;Brucker S.Y.;Cardoso F.;Carey L.;Ciruelos E.;Cuzick J.;Denkert C.;Di Leo A.;Ejlertsen B.;Francis P.;Galimberti V.;Garber J.;Gulluoglu B.;Goodwin P.;Harbeck N.;Hayes D.F.;Chiun-Sheng Huang;Huober J.;Khaled H.;Jassem J.;Jiang Z.;Karlsson P.;Morrow M.;Orecchia R.;Osborne K.C.;Pagani O.;Partridge A.H.;Pritchard K.;Ro J.;Rutgers E.J.T.;Sedlmayer F.;Semiglazov V.;Shao Z.;Smith I.;Toi M.;Tutt A.;Viale G.;Watanabe T.;Whelan T.J.;Xu B.;On Behalf Of The Panel Members Of The St Gallen International Expert Consensus On The Primary Therapy Of Early Breast Cancer 2017 |
| 臺大學術典藏 |
2017 |
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
|
Ataseven, B.; Verrill, M.; De Laurentiis, M.; Jung, K.H.; Azim, H.A.; Al-Sakaff, N.; Lauer, S.; Shing, M.; Pivot, X.; Koroveshi, D.; Bouzid, K.; Casalnuovo, M.; Cascallar, D.; Korbenfeld, E.P.; Bastick, P.; Beith, J.; Colosimo, M.; Friedl; er, M.; Ganju, V.; Green, M.; Patterson, K.; Redfern, A.; Richardson, G.; Ceric, T.; Gordana, K.; Beato, C.A.; Ferrari, M.; Hegg, R.; Helena, V.; Ismael, G.F.; Lessa, A.E.; Mano, M.; Morelle, A.; Nogueira, J.A.; Timcheva, K.; Tomova, A.; Tsakova, M.; Zlatareva-Petrova, A.; Asselah, J.; Assi, H.; Brezden-Masley, C.; Chia, S.; Freedman, O.; Harb, M.; Joy, A.A.; Kulkarni, S.; Prady, C.; Gaete, A.A.A.; Matamala, L.; Torres, R.; Yanez, E.; Franco, S.; Urrego, M.; Gugi?, D.; Vrbanec, D.; Melichar, B.; Prausov; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
|
Chow, L.W.C. and Biganzoli, L. and Leo, A.D. and Kuroi, K. and Han, H.S. and Patel, J. and Huang, C.S. and Lu, Y.S. and Zhu, L. and Chow, C.Y.C. and Loo, W.T.Y. and Gl\\uck, S. and Toi, M.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
A longitudinal study of diurnal cortisol patterns and associated factors in breast cancer patients from the transition stage of the end of active cancer treatment to post-treatment survivorship
|
Hsiao F.-H.;Jow G.-M.;Kuo W.-H.;Wang M.-Y.;Chang K.-J.;Lai Y.-M.;Chen Y.-T.;Chiun-Sheng Huang; Hsiao F.-H.; Jow G.-M.; Kuo W.-H.; Wang M.-Y.; Chang K.-J.; Lai Y.-M.; Chen Y.-T.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2017 |
Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients
|
Toi M.; Gl?ck S.; Loo W.T.Y.; Chow C.Y.C.; Zhu L.; Lu Y.S.; CHIUN-SHENG HUANG; Patel J.; Chow L.W.C.;Biganzoli L.;Leo A.D.;Kuroi K.;Han H.S.;Patel J.;Chiun-Sheng Huang;Lu Y.S.;Zhu L.;Chow C.Y.C.;Loo W.T.Y.;Gl?Ck S.;Toi M.; Chow L.W.C.; Biganzoli L.; Leo A.D.; Kuroi K.; Han H.S. |
| 臺大學術典藏 |
2017 |
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
Kim S.-B.;Maslyar D.J.;Dent R.;Im S.-A.;Espi? M.;Blau S.;Tan A.R.;Isakoff S.J.;Oliveira M.;Saura C.;Wongchenko M.J.;Kapp A.V.;Chan W.Y.;Singel S.M.;Baselga J.;Kim S.-B.;Lee K.S.;Im S.-A.;Espi? M.;Wang H.-C.;Blau S.;Dent R.;Tan A.;Sohn J.H.;De Laurentiis M.;Estevez L.G.;Chiun-Sheng Huang;Romieu G.;Velez M.;Villanueva R.;Conte P.F.;Dakhil S.;Debled M.;Martin A.G.;Hurvitz S.;Kim J.H.;Levy C.;Oliveira M.;Rovira P.S.;Seo J.H.;Valero V.;Vidal G.;Wong A.;Allison M.A.K.;Figlin R.;Chan D.;Chen S.-C.;Chen Y.-H.;Cobleigh M.;De Braud F.;Dirix L.;Hansen V.;Bessard A.H.;Iannotti N.;Isakoff S.;Lawler W.;Monta?O A.;Salkini M.;Seigel L.;On Behalf Of The, Lotus Investigators, Lotus Investigators; Estevez L.G.; De Laurentiis M.; Sohn J.H.; Wang H.-C.; Blau S.; Dent R.; Tan A.; Espi? M.; Im S.-A.; Lee K.S.; Kim S.-B.; Baselga J.; Kim S.-B.; Maslyar D.J.; Dent R.; Im S.-A.; Espi? M.; Blau S.; Tan A.R.; Isakoff S.J.; Oliveira M.; Saura C.; Wongchenko M.J.; Kapp A.V.; Chan W.Y.; Singel S.M.; Allison M.A.K.; Vidal G.; Wong A.; Valero V.; Seo J.H.; CHIUN-SHENG HUANG; Romieu G.; Velez M.; Villanueva R.; Conte P.F.; Dakhil S.; Debled M.; Martin A.G.; Hurvitz S.; Kim J.H.; Levy C.; Oliveira M.; Rovira P.S.; on behalf of the, LOTUS investigators, LOTUS investigators; Seigel L.; Salkini M.; Monta?o A.; Figlin R.; Chan D.; Chen S.-C.; Chen Y.-H.; Cobleigh M.; De Braud F.; Dirix L.; Hansen V.; Bessard A.H.; Iannotti N.; Isakoff S.; Lawler W. |
| 臺大學術典藏 |
2017 |
Computer-aided prediction of axillary lymph node status in breast cancer using tumor surrounding tissue features in ultrasound images
|
Moon W.K.;Lee Y.-W.;Huang Y.-S.;Lee S.H.;Bae M.S.;Yi A.;Chiun-Sheng Huang;Chang R.-F.; Moon W.K.; Lee Y.-W.; Huang Y.-S.; Lee S.H.; Bae M.S.; Yi A.; CHIUN-SHENG HUANG; Chang R.-F. |
顯示項目 356-365 / 438 (共44頁)
<< < 31 32 33 34 35 36 37 38 39 40 > >>
每頁顯示[10|25|50]項目
|
